Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)-Reference-Cited by-同舟云学术

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)

Published:2002-07 Issue:11 Volume:38 Page:1429-1436
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Van Cutsem E,Dicato M,Wils J,Cunningham D,Diaz-Rubio E,Glimelius B,Haller D,Johnston P,Kerr D,Koehne C.H,Labianca R,Minsky B,Nordlinger B,Roth A,Rougier P,Schmoll H.J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma;Moertel;N. Engl. J. Med.,1990

2. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer;Moertel;J. Clin. Oncol.,1995

3. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer;J. Clin. Oncol.,1992

4. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer;Wolmark;J. Clin. Oncol.,1993

5. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer;Lancet,1995

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-lymphocyte ratio predicts poor prognosis in stage II / III colon and rectum cancer;Journal of Health Sciences and Medicine;2022-03-15

2. Present Situation and Prospect of Diagnosis and Treatment of Colorectal Cancer;Multidisciplinary Management of Liver Metastases in Colorectal Cancer;2016-12-15

3. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool;Health and Quality of Life Outcomes;2015-05-19

5. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients;The American Journal of Surgery;2014-08